CD79A and myeloid sarcoma: Breakthrough research reported that some gut microbiome taxa enriched in MS patients directly interact with IgA-producing cells at the gut lining; the latter translocate to the brain cells and locally produce immunoglobulin A (IgA), which mediates severe inflammation.